TRPC antagonist 1 exhibits significant anti-glioblastoma efficacy against U87 cell line in vitro; it is a potent antagonist of TRP channels (TRPC), with IC50 values of 2.4 μM, 12.2 μM, 7.6 μM, 2.9 μM, and 3.4 μM for TRPC3, TRPC4, TRPC5, TRPC6, and TRPC7, respectively.